Article Versions Notes

Minoli L, Licenziato L, Kocikowski M, Cino M, Dziubek K, Iussich S, Fanelli A, Morello E, Martano M, Hupp T, et al. Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma. Cancers. 2022; 14(24):6188. https://doi.org/10.3390/cancers14246188

Minoli, Lucia, Luca Licenziato, Mikolaj Kocikowski, Marzia Cino, Katarzyna Dziubek, Selina Iussich, Antonella Fanelli, Emanuela Morello, Marina Martano, Ted Hupp, and et al. 2022. "Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma" Cancers 14, no. 24: 6188. https://doi.org/10.3390/cancers14246188

Minoli, L., Licenziato, L., Kocikowski, M., Cino, M., Dziubek, K., Iussich, S., Fanelli, A., Morello, E., Martano, M., Hupp, T., Vojtesek, B., Parys, M., & Aresu, L. (2022). Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma. Cancers, 14(24), 6188. https://doi.org/10.3390/cancers14246188